Literature DB >> 26840230

Electrical impedance myography in facioscapulohumeral muscular dystrophy.

Jeffrey M Statland1, Chad Heatwole2, Katy Eichinger2, Nuran Dilek2, William B Martens2, Rabi Tawil2.   

Abstract

INTRODUCTION: In this study we determined the reliability and validity of electrical impedance myography (EIM) in facioscapulohumeral muscular dystrophy (FSHD).
METHODS: We performed a prospective study of EIM on 16 bilateral limb and trunk muscles in 35 genetically defined and clinically affected FSHD patients (reliability testing on 18 patients). Summary scores based on body region were derived. Reactance and phase (50 and 100 kHz) were compared with measures of strength, FSHD disease severity, and functional outcomes.
RESULTS: Participants were mostly men, mean age 53.0 years, and included a full range of severity. Limb and trunk muscles showed good to excellent reliability [intraclass correlation coefficients (ICC) 0.72-0.99]. Summary scores for the arm, leg, and trunk showed excellent reliability (ICC 0.89-0.98). Reactance was the most sensitive EIM parameter to a broad range of FSHD disease metrics.
CONCLUSIONS: EIM is a reliable measure of muscle composition in FSHD that offers the possibility to serially evaluate affected muscles. Muscle Nerve 54: 696-701, 2016.
© 2016 Wiley Periodicals, Inc.

Entities:  

Keywords:  electrical impedance myography; facioscapulohumeral muscular dystrophy; muscle composition; muscular dystrophy; outcome measure

Mesh:

Year:  2016        PMID: 26840230      PMCID: PMC4972708          DOI: 10.1002/mus.25065

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  29 in total

1.  Reliability and feasibility of the six minute walk test in subjects with myotonic dystrophy.

Authors:  Marie Kierkegaard; Anna Tollbäck
Journal:  Neuromuscul Disord       Date:  2007-09-14       Impact factor: 4.296

2.  A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. The FSH-DY Group.

Authors: 
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

3.  A portable system for the assessment of neuromuscular diseases with electrical impedance myography.

Authors:  O T Ogunnika; S B Rutkove; H Ma; P M Fogerson; M Scharfstein; R C Cooper; J L Dawson
Journal:  J Med Eng Technol       Date:  2010-07-29

4.  A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score.

Authors:  Costanza Lamperti; Greta Fabbri; Liliana Vercelli; Roberto D'Amico; Roberto Frusciante; Emanuela Bonifazi; Chiara Fiorillo; Carlo Borsato; Michelangelo Cao; Maura Servida; Francesca Greco; Rita Di Leo; Leda Volpi; Claudia Manzoli; Paola Cudia; Ebe Pastorello; Leopoldo Ricciardi; Gabriele Siciliano; Giuliana Galluzzi; Carmelo Rodolico; Lucio Santoro; Giuliano Tomelleri; Corrado Angelini; Enzo Ricci; Laura Palmucci; Maurizio Moggio; Rossella Tupler
Journal:  Muscle Nerve       Date:  2010-08       Impact factor: 3.217

5.  Facioscapulohumeral muscular dystrophy in the Dutch population.

Authors:  G W Padberg; R R Frants; O F Brouwer; C Wijmenga; E Bakker; L A Sandkuijl
Journal:  Muscle Nerve Suppl       Date:  1995

6.  Facioscapulohumeral dystrophy natural history study: standardization of testing procedures and reliability of measurements. The FSH DY Group.

Authors:  K E Personius; S Pandya; W M King; R Tawil; M P McDermott
Journal:  Phys Ther       Date:  1994-03

7.  The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy.

Authors:  Craig M McDonald; Erik K Henricson; Jay J Han; R Ted Abresch; Alina Nicorici; Gary L Elfring; Leone Atkinson; Allen Reha; Samit Hirawat; Langdon L Miller
Journal:  Muscle Nerve       Date:  2010-04       Impact factor: 3.217

8.  Risk of functional impairment in Facioscapulohumeral muscular dystrophy.

Authors:  Jeffrey M Statland; Rabi Tawil
Journal:  Muscle Nerve       Date:  2014-02-10       Impact factor: 3.217

9.  Reevaluating measures of disease progression in facioscapulohumeral muscular dystrophy.

Authors:  Jeffrey M Statland; Michael P McDermott; Chad Heatwole; William B Martens; Shree Pandya; E L van der Kooi; John T Kissel; Kathryn R Wagner; Rabi Tawil
Journal:  Neuromuscul Disord       Date:  2013-02-11       Impact factor: 4.296

10.  Distinct disease phases in muscles of facioscapulohumeral dystrophy patients identified by MR detected fat infiltration.

Authors:  Barbara H Janssen; Nicoline B M Voet; Christine I Nabuurs; Hermien E Kan; Jacky W J de Rooy; Alexander C Geurts; George W Padberg; Baziel G M van Engelen; Arend Heerschap
Journal:  PLoS One       Date:  2014-01-14       Impact factor: 3.240

View more
  11 in total

Review 1.  Electrical Impedance Myography and Its Applications in Neuromuscular Disorders.

Authors:  Benjamin Sanchez; Seward B Rutkove
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

2.  Electrical impedance myography in facioscapulohumeral muscular dystrophy: A 1-year follow-up study.

Authors:  Karlien Mul; Chad Heatwole; Katy Eichinger; Nuran Dilek; William B Martens; Baziel G M Van Engelen; Rabi Tawil; Jeffrey M Statland
Journal:  Muscle Nerve       Date:  2018-04-17       Impact factor: 3.217

Review 3.  Therapeutic Approaches in Facioscapulohumeral Muscular Dystrophy.

Authors:  Justin Cohen; Alec DeSimone; Monkol Lek; Angela Lek
Journal:  Trends Mol Med       Date:  2020-10-19       Impact factor: 11.951

Review 4.  Facioscapulohumeral Muscular Dystrophy: Update on Pathogenesis and Future Treatments.

Authors:  Johanna Hamel; Rabi Tawil
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

Review 5.  The Value of Imaging and Composition-Based Biomarkers in Duchenne Muscular Dystrophy Clinical Trials.

Authors:  Stephen M Chrzanowski; Basil T Darras; Seward B Rutkove
Journal:  Neurotherapeutics       Date:  2020-01       Impact factor: 7.620

6.  Modeling and Reproducibility of Twin Concentric Electrical Impedance Myography.

Authors:  Marti Martinez de Morentin Cardoner; Hyeuknam Kwon; Hilda Victoria Gutierrez Pulido; Janice Nagy; Seward Rutkove; Benjamin Sanchez
Journal:  IEEE Trans Biomed Eng       Date:  2021-09-20       Impact factor: 4.756

7.  Non-invasive evaluation of muscle disease in the canine model of Duchenne muscular dystrophy by electrical impedance myography.

Authors:  Chady H Hakim; Alex Mijailovic; Thais B Lessa; Joan R Coates; Carmen Shin; Seward B Rutkove; Dongsheng Duan
Journal:  PLoS One       Date:  2017-03-24       Impact factor: 3.240

Review 8.  Facioscapulohumeral muscular dystrophy: genetics, gene activation and downstream signalling with regard to recent therapeutic approaches: an update.

Authors:  Teresa Schätzl; Lars Kaiser; Hans-Peter Deigner
Journal:  Orphanet J Rare Dis       Date:  2021-03-12       Impact factor: 4.123

9.  Electrical Properties of Lumbar Paraspinal Muscles in Young Adults With and Without Chronic Low Back Pain Based on Electrical Impedance Myography: A Cross-Sectional Study.

Authors:  Hongjiang Wang; Jiaxuan Zheng; Qiuhua Yu; Ziyan Fan; Wai Leung Ambrose Lo; Le Li; Chuhuai Wang
Journal:  Front Neurol       Date:  2022-02-17       Impact factor: 4.003

10.  Clinical trial readiness to solve barriers to drug development in FSHD (ReSolve): protocol of a large, international, multi-center prospective study.

Authors:  Samantha LoRusso; Nicholas E Johnson; Michael P McDermott; Katy Eichinger; Russell J Butterfield; Elena Carraro; Kiley Higgs; Leann Lewis; Karlien Mul; Sabrina Sacconi; Valeria A Sansone; Perry Shieh; Baziel van Engelen; Kathryn Wagner; Leo Wang; Jeffrey M Statland; Rabi Tawil
Journal:  BMC Neurol       Date:  2019-09-10       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.